BIONXT SOLUTIONS INC. Total Liabilities
BIONXT SOLUTIONS INC. total liabilities. Based on the latest financial reports, BIONXT SOLUTIONS INC. (BXT) has total liabilities worth €7.65 Million EUR (≈ $8.94 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See BXT defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Total Liabilities of BIONXT SOLUTIONS INC. (2021–2025)
Total liabilities of BIONXT SOLUTIONS INC. from 2021 to 2025. This chart illustrates how BIONXT SOLUTIONS INC.'s total liabilities have evolved over time, based on quarterly financial data.
BIONXT SOLUTIONS INC. Competitors by Total Liabilities
The table below lists competitors of BIONXT SOLUTIONS INC. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
CNTus Sungjin Co. Ltd.
KQ:352700
|
Korea | ₩11.41 Billion |
|
Altech Chemicals Ltd
F:A3Y
|
Germany | €16.45 Million |
|
Cogra 48 Société Anonyme
PA:ALCOG
|
France | €12.10 Million |
|
5TH PLANET GAMES DK -50
F:2HG1
|
Germany | €13.94 Million |
|
S2 Resources Ltd
AU:S2R
|
Australia | AU$2.80 Million |
|
KB Autosys Co. Ltd
KQ:024120
|
Korea | ₩125.72 Billion |
|
Pili International Multimedia Co Ltd
TWO:8450
|
Taiwan | NT$559.52 Million |
|
BELLINI NAUTICA S.P.A.
F:F2F
|
Germany | €20.44 Million |
Liability Composition Analysis (2021–2025)
This chart breaks down BIONXT SOLUTIONS INC.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see BXT current and non-current assets.
Liquidity & Leverage Metrics
BIONXT SOLUTIONS INC. Total Liabilities Ratios Explained
BIONXT SOLUTIONS INC. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.01 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.05 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 22.92 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how BIONXT SOLUTIONS INC.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for BIONXT SOLUTIONS INC. (2021–2025)
The table below shows the annual total liabilities of BIONXT SOLUTIONS INC. from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €9.96 Million ≈ $11.64 Million |
+18.11% |
| 2024-12-31 | €8.43 Million ≈ $9.86 Million |
+28.71% |
| 2023-12-31 | €6.55 Million ≈ $7.66 Million |
+14.10% |
| 2022-12-31 | €5.74 Million ≈ $6.71 Million |
-28.75% |
| 2021-12-31 | €8.06 Million ≈ $9.42 Million |
-- |
About BIONXT SOLUTIONS INC.
BioNxt Solutions Inc. engages in research, development, manufacture, and sale of next generation drug formulations and delivery systems in Austria, Germany, and Switzerland. The company provides BNT23001for the treatment of multiple sclerosis and myasthenia gravis; BNT24002 for the treatment of lupus nephritis; BNT24003 for the treatment of rheumatoid arthritis; BNT24004 for longevity and anti-ag… Read more